Jennifer Creel
Nessuna posizione attualmente
Storia della carriera di Jennifer Creel
Precedenti posizioni note di Jennifer Creel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ADC THERAPEUTICS SA | Director of Finance/CFO | 20/05/2020 | 19/12/2022 |
| CELGENE | Corporate Officer/Principal | 01/01/2008 | 01/01/2020 |
Formazione di Jennifer Creel
| The College of William & Mary | Undergraduate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Svizzera | 2 |
Posizioni
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ADC THERAPEUTICS SA | Health Technology |
| Aziende private | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Jennifer Creel
- Esperienza
